- Home
- TSHA vs GHG Comparison
TSHA vs GHG Comparison
Compare TSHA & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- GHG
- Stock Information
- Founded
- TSHA 2019
- GHG 2004
- Country
- TSHA United States
- GHG China
- Employees
- TSHA N/A
- GHG N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- TSHA Health Care
- GHG Consumer Discretionary
- Exchange
- TSHA Nasdaq
- GHG Nasdaq
- Market Cap
- TSHA 313.6M
- GHG 259.8M
- IPO Year
- TSHA 2020
- GHG 2018
- Fundamental
- Price
- TSHA $1.53
- GHG $2.47
- Analyst Decision
- TSHA Strong Buy
- GHG
- Analyst Count
- TSHA 8
- GHG 0
- Target Price
- TSHA $6.63
- GHG N/A
- AVG Volume (30 Days)
- TSHA 2.3M
- GHG 8.2K
- Earning Date
- TSHA 11-13-2024
- GHG 02-25-2025
- Dividend Yield
- TSHA N/A
- GHG 4.05%
- EPS Growth
- TSHA N/A
- GHG N/A
- EPS
- TSHA N/A
- GHG 0.28
- Revenue
- TSHA $9,915,000.00
- GHG $201,166,731.00
- Revenue This Year
- TSHA N/A
- GHG N/A
- Revenue Next Year
- TSHA N/A
- GHG $8.78
- P/E Ratio
- TSHA N/A
- GHG $8.88
- Revenue Growth
- TSHA N/A
- GHG N/A
- 52 Week Low
- TSHA $1.19
- GHG $2.31
- 52 Week High
- TSHA $4.32
- GHG $3.48
- Technical
- Relative Strength Index (RSI)
- TSHA 34.16
- GHG 46.98
- Support Level
- TSHA $1.56
- GHG $2.35
- Resistance Level
- TSHA $1.75
- GHG $2.48
- Average True Range (ATR)
- TSHA 0.16
- GHG 0.08
- MACD
- TSHA -0.02
- GHG 0.01
- Stochastic Oscillator
- TSHA 3.57
- GHG 50.00
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.